Erratum to "MAT cross-reactions or vaccine cross-protection: retrospective study of 863 leptospirosis canine cases" [Heliyon 4 (11) (November 2018) e00869]. [PDF]
André-Fontaine G, Triger L.
europepmc +1 more source
Frailty Exacerbates Disability in Progressive Multiple Sclerosis
ABSTRACT Background To evaluate frailty in severe progressive multiple sclerosis (PMS) and to investigate the underlying mechanisms. Methods This prospective, cross‐sectional, multicenter study enrolled a late severe PMS group requiring skilled nursing (n = 53) and an age, sex, and disease duration‐matched control PMS group (n = 53).
Taylor R. Wicks +10 more
wiley +1 more source
The First Report on the Structure of Polysaccharide Surface Antigens of the Clinical <i>Klebsiella oxytoca</i> 0.062 Strain and the Contribution in the Serological Cross-Reactions. [PDF]
Palusiak A, Turska-Szewczuk A.
europepmc +1 more source
Differentiating of cross-reactions in patients with latex allergy with the use of ISAC test. [PDF]
Chełmińska M +4 more
europepmc +1 more source
RETRACTED: Exploration of dual solutions for an enhanced cross liquid flow past a moving wedge under the significant impacts of activation energy and chemical reaction [PDF]
Umair Khan +4 more
openalex +1 more source
Post‐COVID Fatigue Is Associated With Reduced Cortical Thickness After Hospitalization
ABSTRACT Objective Neuropsychiatric symptoms are among the most prevalent sequelae of COVID‐19, particularly among hospitalized patients. Recent research has identified volumetric brain changes associated with COVID‐19. However, it currently remains poorly understood how brain changes relate to post‐COVID fatigue and cognitive deficits.
Tim J. Hartung +190 more
wiley +1 more source
Compensating for cross-reactions using avidity and computation in a suspension multiplex immunoassay for serotyping of Zika versus other flavivirus infections. [PDF]
Rönnberg B +6 more
europepmc +1 more source
Discovery and Targeted Proteomic Studies Reveal Striatal Markers Validated for Huntington's Disease
ABSTRACT Objective Clinical trials for Huntington's disease (HD) enrolling persons before clinical motor diagnosis (CMD) lack validated biomarkers. This study aimed to conduct an unbiased discovery analysis and a targeted examination of proteomic biomarkers scrutinized by clinical validation. Methods Cerebrospinal fluid was obtained from PREDICT‐HD and
Daniel Chelsky +8 more
wiley +1 more source

